There is none.
If you were expecting me to share some magic key to super high returns, you must be disappointed. It is amazing that there is an entire segment of the financial industry which is into selling all kinds of special ways of making very high returns with minimal risk and absolutely no effort. I will not blame the seller alone for selling snake oil. They would not be able to sell this garbage, if there was no demand for it.
If one leaves aside the clueless and the greedy, the rest of the investors still live under several myths. Let’s look at some of the prevailing myths
Finding a multi-bagger is key to high returns
The number one aspiration of a lot of investors is to find the elusive multi-bagger or better yet a ten bagger. If one can find and invest in a multi-bagger, then he or she is all set for life.
I don’t deny the thrill of investing in a multi-bagger. However unless one has a focused portfolio (with 3-5 stocks), a multi-bagger will not make a huge difference to the overall returns.
The problem with focusing on multi-baggers is that one loses sight of the main objective (getting good portfolio returns) and ends up confusing the means with the end. A lot of times a mindless focus on multi-baggers blinds one to good opportunities, where one can make good returns (30-40%) in a decent period of time.
In addition to the above problem, new investors become susceptible to fly by night operators and other shady services which promise multi-baggers and quick returns.
Finally multi-baggers are the result of a good investing process, patience of holding the stock over a long period of time and ample luck.
Leverage
I have heard from some readers that they have considerable leverage in their portfolio and it has helped them to get high returns.
I am personally against leverage. High leverage is enjoyable when the going is good and one is making high returns, but it can kill your financial well being when things go wrong. The whole 2008-2009 financial disaster was a lesson in excess leverage, both by individuals and financial institution.
John maynard Keynes said it best – The markets can remain irrational longer than you can remain solvent.
Inside information
The other common myth I have heard is that the markets are completely rigged and the only way to get high returns is to have access to insider information.
That may be true. It is quite possible that there are several shady operators in the market who try to manipulate the market and have been able to make a killing as a result.
It is however incorrect to blame the market operators alone for the losses of the small investor. A lot of time, cheats and con artist are able to take advantage of others due to their greed and fear. This is not limited to stock markets alone and one has heard of such stories in lots of other cases, especially if money is involved.
Super high intellect
The other common myth is that one is born with some kind of ‘finance’ gene. Such super talented investors can make money effortlessly and are destined for greatness. This myth is not limited to finance alone and extends to a lot of other areas such sports and education.
This is an topic is of great interest for me and I have read a lot on it (as I consider myself to have no inborn talent for investing).
The question is this – Is extreme skill, such as being a great investor or great sportsman the result of an inborn talent or something which one can develop over a lifetime?
There are a lot of great books on this topic – talent is overrated and mindset. My personal conclusion for whatever it is worth is this – Extreme skill is the result of a lot of focus and hard work over a long period of time.
There are lot more myths and I could go on and on. The key question is what drives high returns?
The key points which I think drives portfolio returns are quite simple and can be listed in a couple of points
1.Continuous learning with the aim of constant improvement
2.Intellectual humility to learn from one’s mistakes
3.Hard work and intense focus
I don’t have any research to back the above points and state them from my personal experience and what I have read of other super-investors and top performers.
It is true that talent plays a part in one’s success, but intense focus and hard work drives eventual success far more than talent alone. I don’t think there is any great investor out there who has also not worked extremely hard over a long period of time to achieve that level of success. There is nothing natural in picking a good stock.
The counter point to the above statement can be – Do you think that working hard will make you a warren buffett or rakesh jhunjhunwala ?
I think this statement or thought misses the point. I may not become a warren buffett (highly unlikely), but working hard and focusing on this skill over a long period of time will definitely make me a much better and hopefully successful investor.
Borrowed Idea – Gujarat reclaimed rubber products
A disclosure first – This is a completely borrowed idea. I originally saw this idea on Ayush’s blog and started investigating it on my own. I had some discussions with him on the phone and liked the story behind the company.
The idea is a borrowed one, though hopefully the thinking is not (Ofcourse if the idea succeeds it would become my original idea as i would conveniently forget the source in due time 🙂 ). I personally have no qualms of borrowing ideas from other smart investors like ayush (would highly recommend following his blog), though I will provide due to attribution to the original idea if I post about it.
I will not repeat some of the analysis here as ayush has done a great job of it. You can find the analysis here. Let me add some additional thoughts to the analysis
Competitive analysis
The Company has been able to sustain a fairly high growth and profitability for the last 8-10 years. The company currently enjoys a 35%+ market share in its business niche which is characterized by a large number of players from the unorganized sector.
The company has been expanding rapidly and is now enjoying the benefits of scale in production and sales. The Working capital turns have been going up steadily over the years which is an indication of the operating leverage (Fixed asset turns have not increased as much due to constant capacity addition). The company is now one of the largest company in its sector and is now exporting almost 57% of its total turnover. An effective sales and marketing organization is required to develop and sustain an export business as it requires a close relationships with the OEMs (tyre manufacturers and other users of rubber)
The competitive intensity from any large players is likely to low as this is not a big and attractive segment for any big player. The company enjoys a substantial competitive advantage over smaller player due to economies of scale, customer relationships, strong sourcing network (for waste rubber) and ability to invest in research.
Risk
The main threat is low cost import of tyres from china which can hurt the OEMs directly and Gujarat reclaim indirectly. In addition this is a very competitive industry with a lot of competitors and it is unlikely the company can earn very high profits for a long time.
The price of rubber also plays an important part in the profitability. As the price of virgin rubber has increased, the substitution by reclaimed rubber has gone up too. The substitution effect may slow down once the price of rubber starts dropping.
Competition
The company does not seem to have any major listed competitors, though there seem to be a lot of smaller competitors. A company like Indag rubber is not really a direct competitor even though they operate in the tyre industry. Gujarat reclaim provides cheap substitution of a raw material used in tyres, whereas indag provides a substitute for the end product – tyres itself (via re-treading).
Valuation
The fair value of the company can be estimated to be between 1700-2000 with an assumption of 8-9% net margins and growth in the range of 10-11 %. The company is selling at a decent discount to fair value and would be quite attractive if the price drops below 800.
Disclosure: I have a position in the stock. Please read disclaimer at end of the blog.
Evaluating management
The number one criteria which determines the performance of a company is the quality of the management. This is also the most difficult criteria to evaluate and one’s degree of success in evaluating the management determines the eventual success of the specific stock pick and long term returns of the portfolio.
If you are into trading, momentum investing or any other quantitative methods, then management or the nature of the business may not matter. However if like me, your approach to investing is to evaluate the long term economics and performance of a company and purchase the stock at a meaningful discount to the fair value, then management matters a lot.
Although it is easy to state the above point, it is not easy to execute it. There are no fixed formulae to evaluate management. A lot of times I have seen people either completely ignore the issue of management quality or get too focused on it. I will turn to the issue of too much focus later in the post.
I myself do not have any magic formulae to evaluate management. However I have a list of points (in my valuation template) against which I run a check on the company’s management. Let me discuss a few points below. These points are not exhaustive on their own, but may be a good place to start
Capital allocation record: This is the number one responsibility of the management. How does the management invest the free cash generated by the business? Is the management investing it in new opportunities at a high return (preferably more than 15%) or is the management chasing growth for growth’s sake?
A single year of good or bad performance may not be important. One should look at the track record for a number of years to evaluate the performance of the management on this count. A good way to do it is to look the incremental return on new investments. The formulae for calculating this number is simple – (net profit for current year – profit for five years back)/(Fixed asset + working capital for current year – same number five years back).
The above number should give you an idea of how well the management has invested in the last five or more years. A poor record means that the management is failing at its core responsibility.
Management compensation: A good management should be compensated well. However the compensation should be in line with the industry and within reasonable limits. I typically look for compensation to be between 3-5% of profits. Any more than that is a concern for me.
Shareholder communication: Does the management discuss the bad and good openly and with honesty. Do they crow about the good news and hide the bad news? Unfortunately in India shareholder communication is almost non-existent. Even companies doing well give a one page write up of the performance. Except for IT companies and a few others, shareholder communication is joke.
Accounting practice: Is the management conservative in accounting. Look for how the management is accounting for investments and hedge losses. Are they conservative in accounting for old debt (more than 6 months). Does the management have reasonable pension accounting?
Conflict of interest : related party transactions is the place to look for this point. I am on a watchout for any large transaction between affiliated companies (sister companies owned by management).
Past reputation: Has the management been reprimanded by SEBI or any other bodies? Do they have a past reputation of taking the investor for a ride?
I use the above list and more to evaluate the management. There is no formulae or wieghtage for any criteria and the eventual decision is bound to depend on past experience and a subjective assessment of all the factors. At the same time, if the management has a serious negative on any of the above points such as shoddy accounting or poor capital allocation record, I will just avoid the company and move on.
In the end ,there are a lot more companies to choose from and I would rather hold the cash than take grief from investing with a crooked management, not matter how good the numbers.
Over focus on the management
The other extreme I have seen is when investors fall completely in love with the company and follow each and every word and action of the management.
During the bull run of 2006-2007, I saw a lot of investors discuss and dissect every interview and utterance of the management on stock boards. I am all for tracking a company and reviewing the quarterly numbers and conference calls (if the management does that), however I find it silly to read every possible interview and press release and try to make sense out it.
I think companies which are over communicative and share every small scrap of information are focused too much on their media profile and may in some cases, be losing focus on the running their business. Investor who track every twist and turn of the company, risk missing the big picture as they convince themselves that they now understand the company much better as they have been following it very closely.
Getting fooled by management
Even if one is diligent in the analysis and evaluates the management from all aspects, it is possible to get fooled by the management – aka satyam.
So should one stop investing ? By that measure, one should not drive as you can have an accident.
My answer to reducing the risk is diversification. You do not put all your money into a single company. If one does a decent job of evaluating the management, the chances of getting cheated by a crooked management are reduced if not eliminated. The entire idea of investing is to manage risk with appropriate returns to compensate for it.
A quick note on the paid service
First, my apologies to all of you who have written to me. I have not responded to anyone.
I grossly underestimated the response. My initial plan was to respond to each email personally, but after a day or so I dropped it as the numbers went way above my estimates. A lot of you have expressed interest, but have also asked for the details of the service (rightly so !).
I am in the process of setting up an email service and would recommend anyone who is interested in the paid service to subscribe to it. I plan to use this email message service to discuss more details about the service and also share some exclusive content on it (the carrot for subscribing:)).
Some of you have raised the point on what will happen to this blog after I launch my service. Will it undergo a change? I have no plans to change the nature of the blog. It will always remain free and I will continue to share some of the ideas on the blog as before.
I however do not want to use this blog to broadcast about the service too much (though I will have occasional updates) as there are a lot of readers on the blog who would not be interested in it and I don’t want to spoil their experience with such posts.
As always, my thanks to all of you for reading and following my blog.
Stock analysis : FDC ltd
About
FDC is an Indian Pharmaceuticals company with an operating history of more than 50 years. The company is into formulations, synthetics, nutraceuticals and bio-tech with a focus on therapeutic groups of ORS, opthalmologicals, dermatologicals, Anti-biotics, Cardio and diabetes. The company has several well known brands such as electral, enerzal etc.
Financials
The company has maintained an ROE in excess of 20% for the last 10 years. In addition the company is conservatively financed with zero debt and excess cash position during the same period.
The company has maintained fixed asset turns (sales/ fixed asset) at the same levels by investing in fixed assets in line with the topline growth. The working capital turns (sales/ working capital) have improved from around 5 to 9+ levels in the last 10 years. This improvement has been driven mainly by an improvement in receivable turns (sales/ account receivables).
The net margins have improved from the 15% levels to 20% levels mainly due to drop in raw material prices.
Positives
The company has maintained a high ROE with a very conservative balance sheet. The company has maintained excess cash and financed growth with the free cash flow generated from operations.
The company has also been able to maintain a topline and bottom-line growth in excess of 15% in spite of high competition and change in the operating environment (changes in patent laws in 2005).The company announced a buy-back in 2008 and has been able to use the excess cash to reduce the number of outstanding shares.
The company has a consistent track record of introducing several new products every year and currently spends almost 3% of sales on R&D which is a crucial investment in the pharma business.
The company is conservative in other aspects of the business such as foreign acquisitions (none) or expanding in the foreign markets (exports are 10% of total turnover).
Risks
The company operates in a business characterized by a high level of competition from domestic and deep pocketed global pharma companies. Although company spends a substantial amount on R&D, global players such as JNJ spend in excess of 10% on R&D. As a result the R&D spend of the company is small by most standards and can be utilized only to develop the off patent molecules in the form of generics for the local and export market.
This is a very competitive business with low to moderate profitability and several other domestic pharma companies such as a CIPLA or Dr reddy’s have a major head start in the space (they are almost 10 times the size of FDC)
In addition the company is also into the consumer health space which is closer to FMCG than pharma products and requires a different set of skills and focus.
Competitive analysis
The industry is characterized by a large number of domestic and foreign competitors. India, China and other BRIC countries are the major growth areas now and all the major companies are now targeting India for growth. The market is already experiencing a high level of competition and activity. One indicator is the number of new product launches and corresponding marketing and sales cost.
The generics opportunity in the export markets of US, Europe and Japan is big with thin margins and high levels of competition.
In case of a drug coming off patent, the pricing typically drops off by more than 60% in the first year and by almost 80% by the third year of patent expiration. As a result these are high risk – high return, limited duration type of opportunities.
Management quality checklist
– Management compensation – Management compensation seems reasonable at less than 3% of net profit.
– Capital allocation record – Fairly good till date. The management has kept the ROE high, inspite of high cash levels. In addition the management has also used the excess capital to buy-back shares which is a sensible decision.
– Shareholder communication – Very sketchy. The mandatory disclosure in terms of the balance sheet, P&L and other schedules are as per the standards. However the company, like other mid cap companies, is very sketchy and does not provide enough discussion on the subjective parts of the business. It gives a very generic overview of the business and has not discussed the plans for the future in detail. If you compare with the annual reports of other pharma companies like Dr reddy’s, the differences are glaring. I can live without too much detail for a steel or a cement company as the numbers give a good picture, but for a pharma or IT company the subjective details are important to evaluate the future of the company. This is a big negative for me.
– Accounting practice – Seems ok. Nothing out of the ordinary
– Conflict of interest – Related party transactions seem fine. I could not find anything out of the ordinary.
Competitor analysis (top 2-3 competitors)
The main competitors for FDC are the domestic pharma companies such as Dr reddy’s, Cipla, Sun pharma and Ranbaxy. These companies are much larger than FDC and are not strictly comparable. At the same time, competition in the pharma industry is by segment. The term pharma is too broad for comparison. If one has to compare competitors, it would be by therapeutic groups such as anti-bioitics, cardio-vasculars, opthalmologicals etc.
FDC has a leading position in some segments such ORS and a few leading brands such as ZIPANT-D SR, 1-AL etc.
The net margins for FDC are comparable to the other top companies and the ROE is also in the same range of 20%+. The overall business risk to FDC is much lesser as the company has not expanded aggressively in the foreign markets. Conversely the returns and growth have been lower too compared to the other aggressive competitors such as Dr reddys, SUN pharma etc.
Valuation
A DCF calculation with a net margins of around 16-18% and 10-12% growth (both assumptions are conservative based on past history), gives a fair value of 120-140 per share. The company would be a good value below a price of 70 per share or if the company started doing far better than the assumptions in the above valuation.
Conclusion
FDC has been a conservatively managed company which has done fairly well in the past 10 years. The company has expanded mainly in the domestic markets and is now expanding slowly into exports via new ANDA filings. The company is likely to maintain a 10-15% growth in line with the market growth with some additional growth coming from exports.
As an investor, I would expect the company to give me moderate returns at low risk. I don’t think the company can be a multi-bagger in the short to medium term.
Disclosure : I have position in the stock. The above analysis is not to recommend the stock. So please do your own homework on it.
Quarterly result review – Some standouts
The quarterly result for most companies are out and I have been reviewing the results of the companies in my portfolio. In most of the cases the results were as expected, but in some cases there have been some unexpected changes – in some cases good and a few not so good.
Cheviot Company – Now this is a company most of you would wonder, why the hell even invest in it? Cheviot is in the business of jute manufacturing and is located in West Bengal. I have written about company here and continue to hold a small position. This company operates in an unattractive industry in a business unfriendly state. The company workers go on a strike every alternate year and the compensation costs are now in excess of 15%.
If the above is not enough, the export market of the company has stagnated in the last few years due to the recession. So why hold this stock?
The company sells for less than cash on books, has been able to earn more than 15% on invested capital and pays out a fair dividend. The company is now focusing on the local market and has started growing again. However, all said and done, it is not the best of my picks although I have not lost money on it and I will exit in due course now.
Facor alloys – I wrote about this company recently here. The current quarter numbers are very good. If one excludes the one time power related charges, the company has earned almost 14 Crs in the quarter which is almost equal to the entire profit of the previous year.
This is a very cyclical business and one should not extrapolate the quarter numbers. However I think the company should do fine over a business cycle and is still selling cheap.
Lakshmi machine works – The company came out with decent numbers as expected. The key news on the company is that company has initiated a buyback which is good way of utilizing capital. I think the company could have done this earlier when the stock was cheaper, but it is quite likely that the management was conserving cash during the recession.
Gujarat gas – I have discussed the company here. The company came out with good topline and bottom line numbers(20% growth) The company continues to do well and is a well managed company. I personally think that once the company ties up more long term supply sources, it should be able to do even better and think that the fair value will keep increasing at a good rate.
The tech companies (Infosys, NIIT tech etc) – Infosys has come out with average numbers (10% sales growth, profit de-growth) in terms of growth. The company continues to generate a high return on capital, but the growth is now muted due varying factors such as recession in the US, exchange rates and rising costs in India. The valuations are still much higher and assume higher growth in the future. That may very well happen, though I am not betting my money on it – I have reduced my holding by a substantial amount already.
NIIT tech has had miserable performance in the last few years ( have written here about the company). The topline growth was non-existent and the silly foreign currency hedges kept biting the company. Those hedges are now being worked out and hopefully the management would not repeat the same mistake (of putting a multi-year currency hedge). The company has had a good topline and bottom line growth due to increased business in India (some of it is one time). I think the company should continue to give high single digit growth in the next few years.
The stock is not undervalued by a large margin and as a result I have reduced my position substantially.
The quarterly circus
Quarterly earnings are a big drama in the US. It is almost a ritual and every time a company misses its quarterly estimates, the stock gets punished severely. In India, the market was immune from this disease, that is till now. I have been noticing that in the last few quarters, any small slowdown or drop in growth is being punished severely and conversely, upside surprises are being rewarded.
A lot of participants may attribute this to higher efficiency and greater volumes etc. This may very well work for traders and in some cases for long time investors too. However I think it is bad for the companies and investors as a whole. A focus on quarterly numbers can cause management to take short sighted decisions which ends up destroying than creating value for the shareholders (remember Enron ?).
The focus of market on short term earnings may be or may be a good thing from varying points of view, but it is here to stay. In such a scenario, it can work for a long term shareholder if you can look past the temporary disappointment and buy the beaten up stock where the company will continue to do well in the future.
Truncated analysis: Shakti Met dor
About
Shakti Met Dor is a leading manufacturer of steel doors since 1995. The company was established primarily to manufacture steel doors, windows, and other building material products to cater to the construction industry. Shakti has expanded its facility to 180,000 Sq.ft of manufacturing and warehouse space capable of producing 300,000 doors and frames. Shakti has seven sales and marketing branches across the major metropolitan cities in India.
Financials
The company is in a niche business and has done fairly well in the last 8-10 years. The ROE has been maintained in excess of 20% with the recent drop due to new CAPEX and higher receivables. The Debt levels have gone up due to the new capacity and due to high additions to accounts receivables in the current year.
The inventory turns has remained at around 10 turns per year and the working capital turns in range of 3.5-4 which seems the reasonable. The total asset turns are at 2.3 which is likely to improve to around 3 with the capex being completed in the last one year.
The one key area of concern is the increase in accounts receivables which is now at around 150 days. I think this needs to be watched closely over the next few years.
Positives
The company operates in a profitable niche and has been able to scale up well in the last few years. The company has been able to deliver a topline growth in excess 20% in the last 10 years and bottom line growth (inspite of the recent drop) in roughly the same range.
The company has recently completed its capex cycle and with the growth in the construction, IT and other user industries, should be able to grow well. In addition the profit margins are likely to improve in the next few years, if the company is able to reduce the debt load and control the raw material costs. The improvement is not a given, but based on the past performance likely to happen.
Risks
There are several key risks in the business. The number one risk is the delisting plan of the company (see here). The management plans to delist the company and has offered around 195/ share. The management holds 56% of the company and needs 34% more to delist. Around 100 shareholders (including the promoters) hold around 90% of the company. I do not have details of these shareholders, but if the management has an informal agreement with them, then the delisting may happen at the proposed price. The minority shareholders holding 10% of the stock will not matter much in the reverse book building process.
A consent order was passed by SEBI on non-compliance of the company of the Substantial Acquisition of Shares and Takeovers Regulations in June 2010. It seems the promoters were acquiring the shares from the market since 1998 and have not disclosed it. This information is missing from the annual reports till 2008-2009. I think this does not inspire confidence
The other risk is the increase in the accounts receivables. This may not be as much as risk as the last quarter of 2010 has seen a sudden increase in topline and hence the year end numbers could be inflated due to that. However one has to watch this number closely as the debt more than 6 months doubled in 2009 and the total debt has increased further in 2010. This increases the risk of bad debt write-offs in the future.
Management quality checklist
– Management compensation: On the higher side. Management compensation is around 12% of net profit
– Capital allocation record: Has been sensible and good till date.
– Shareholder communication – Not good. The management has not been transparent in their communication (see the point on risks above)
– Accounting practice – Seems fine for most part with all the mandatory disclosures in the latest AR.
– Conflict of interest – None in the notes to account. However see the risks section for such incidents.
– Performance track record – Good from a business performance perspective. Corporate governance standards have not been satisfactory.
Conclusion
I started this analysis a few days back and was impressed with the fundamentals. On looking through the BSE filing, I noticed the delisting notice from the company and was thinking of this as an arbitrage or long term opportunity. However the nature of the shareholding (thanks to ninad for pointing that out), I have concerns on how the delisting will work out for the minority shareholder. In addition, some of the past actions do not inspire confidence.
As I discussed in the last post, my valuation template has a checklist which I go through before doing a more detailed analysis on the company. On running through the checklist, I have come across the risks mentioned earlier in this post. I am not too comfortable with those risks and hence inspite of good fundamentals have decided to drop this idea.
Note: If you hold the stock and don’t think the above issues are material enough, it may be so. However I am more conservative and don’t want to put my money on the line to test it out.
Analysis – Mayur uniquoters
About
Mayur uniquoters is in the business of manufacturing synthetic leather. The company’s products find usage in the footwear, automotive, apparel and sports goods industry.
The company supplies to the major automotive companies in the country and abroad. The company has Ford, GM, and Chrysler as customers in the export market and maruti, Tata motors, Hero Honda and other local players as domestic customers. In addition the company is also a supplier to the replacement market.
Financials
The company has performed quite well in the last 8-10 years. The topline has grown by 20% and net profits by 25% in the last 8 years. The current year profits are a cyclically high due to lower raw material costs and exchange related gains.
The company has consistently maintained an ROE of 15%+ and has reduced its debt to 0. The company now has excess of cash of almost 15 crs on its balance sheet.
The current net margins of the company are around 9% which as stated earlier are higher than normal. The normalized profit margins can be assumed to be between 6-7%.
Positives
The company has been doing fairly well in the last few years. The company has been expanding in the export markets and is now an approved supplier to several international OEMs such ford, GM etc. The company has managed to grow inspite of the recession in the export markets.
The company is also a debt free company and can fund the required capex from the cash on the books.
Risks
The company as an OEM supplier is bound to face continued and relentless price pressure from its customers. In addition, the raw material component is around 75% of the sale price and hence the margins of the company are very sensitive to the raw material prices.
The industry is very competitive and it is unlikely that any participant in the industry can earn large profits in the long run. A ROC (return on capital) of 15% would be a good return for an efficiently managed company.
The no.1 risk is not the business, but the management’s intentions. The management awarded themselves around 800000 (around 15% of equity) warrants in 2007-2008 and exercised those warrants at market price. I consider this as a big negative.
As I have stated in the past – warrants are not free and have a value in itself. In addition, the company did not seem to be in need of capital at that time. The sole purpose of issuing the warrants seemed to be to increase the holding of the promoters (which now stands at almost 75%)
Competitive analysis
The product is characterized by minimal brand value for the end customer. The customers (automotives, apparels etc) however value quality and a reliable supplier for the synthetic leather going into their own products. As a result the brand value exists in the mind of the OEM (original equipment manufacturer) buyer.
The industry is characterized by a large number of smaller players in the unorganized sector of the market. The industry is highly competitive with thin margins and poor quality among the smaller players.
The larger companies like Mayur have an opportunity to establish themselves as reliable suppliers to the OEMs and benefit from the economies of scale at the same time.
Management quality checklist
– Management compensation: the management compensation does not appear to be high. The management (who are also the promoters) is paid around 5% of the net profits (around 80 lacs) which although not low, is reasonable.
– Capital allocation record: the capital allocation record seems to be decent. The management has paid down debt, raised dividend over time and now has cash to re-invest in the business. It will be interesting to see how the management will deploy the surplus cash in the future.
– Shareholder communication: disclosure seems to be adequate and in line with other companies.
– Accounting practice: could not see anything out of the ordinary. I need to dig deeper to find if there is anything to be concerned about
– Conflict of interest: other than the warrants, I could not see any related party transactions of concern.
– Performance track record: fairly good so far
Valuation
The company can be assumed to have a normalized profit margin of around 6-7%. As a result the net profit is in the range of 12-13 crs on a normalized basis. As the industry is highly competitive, it is difficult to assume an extended period of high returns for the DCF calculation.
A back of envelope calculation (assuming PE of 12-13) gives a fair value of 150 crs.
Conclusion
The current price is 50% of the fair value. The crucial point is not at arriving at a fair value number, but figuring out the economics and future profitability of the business. If the current numbers can be maintained, then the stock is a bargain.
The other major concern I have is the management attitude towards the minority shareholders. The warrant issue does not inspire confidence and has left a concern in my mind.
I am still halfway through my analysis and will make up my mind after I dig deeper into the company
Disclosure: I have a starter position in the company. A gain on my current position will not pay for than a nice dinner. Please make your investment decisions independently.
Keeping papers in order
This is going to be a fairly odd and short post. I am going to discuss a topic which is not a fun topic, but nonetheless important.
Are your papers in order?
God forbid, if something were to happen to you tomorrow – does your family know the financial situation and has access to all the documentation?
I have heard of a lot of stories and personally encountered some, where the head of the family died and the heirs realized that the paperwork was a mess. I cannot tell you how painful it is to sort such matters.
So, I would suggest each one on us should atleast do the following
· Make a will
· Please add nominee in all your accounts – bank accounts, demats, FD etc
· Have a term insurance which pays in the unfortunate event of your death
· List all your accounts details on a piece of paper, make two copies with one in possession of a close family member and the other one in a locker
· Consolidate your provident fund with your current company – I repeat, please do this now! Getting provident fund issues sorted is a nightmare especially if they are old issues.
· File all the paperwork properly and update it atleast once a year.
I am myself partly guilty on not following all of the above. However I am continuously trying to ensure that my paperwork is in order and plan to clean it up further in the next 1-2 years.
You may be the next warren buffett or Rakesh jhunjhunwala or whatever you are dreaming of, but if your paper work is a mess, your family is going to suffer. The last thing you want is for your family to suffer due to the paperwork in addition to the emotional problems.
A personal experiment
I was recently talking to a friend and he made an interesting comment after looking at my blog.
‘Why do you target beating the market by 2-5%, when you can make 80-90% per annum by trading? I recently started trading and have been making almost 7-8% per month. You should do that too!’
I have heard this comment from a lot of people in the past. The only common feature is that such people trade for a few months, make good returns and extrapolate it to annual returns. Ofcourse, the very same people after losing money in the market make a hasty retreat and are never heard of again.
The quants
I am currently reading a book – The quants. It is quite an entertaining book, though I doubt there is anything to learn from it. The book is about various kinds of traders who use mathematical models and high power computers to trade in the market. It talks about a few hyper successful traders at various firms such Goldman sachs, Morgan Stanley, deutsche bank and hedge funds such as renaissance technologies and citadel investment group.
Some of these trader/ investors were pioneers in their fields, the best of the best and achieved in excess of 30% annual returns over 10 years or more. The best returns were posted by renaissance technologies, which seems to have posted annual returns of around 40% over 2 decades.
The point of the above commentary is this – If you can make 30-40% annual returns for a few years and prove it, there are people who will be ready to handover millions to you to manage. You will be rich and can retire soon. If you can make 40% or more, then you will be considered a god and there is will be books written about you – think of George soros and others.
If you think you can make 70-80% per annum for the next 10 years, then you are day dreaming. If you think you can make these kinds of returns, as my friend suggested while working in a full time job, you should meet a psychiatrist and get a mental health check done.
I think the chance of 1 crore rupees dropping on someone from the sky while walking on the road is higher than making 70-80% per annum for the next 10 years. A 75% return for ten years will give you 269 times you starting capital and 73000 times your capital in 20 years.
A personal experiment
Let me come back to title of my post. If you are new to the blog, let me say it outright – I am biased against short term trading. I do not believe it is the right approach for me. It may work for others, but not for me.
I have said this more out of a general belief and not based on any specific experience, atleast till now.
So, this time around I tried an experiment. I decided to experiment with trading in the last few months. I bought some stocks for day trading, did some momentum buys and sell and did some news based trading too.
At the end of the experiment, I tabulated my results and found that I had made around 18% on my capital in around 3 months. The maximum loss was around 6% and the highest gain on a single position was 11%. The average holding period ranged from 2-3 days to around 15 days.
A success?
If I annualize, then the returns come to around 72%. Should I declare it a success and start trading actively?
I do not term the experience as a success and do not plan to trade ever again. Let me tell you why.
I typically check my long term positions once in a month or a quarter. My broker is one unhappy guy as I have very few orders in a month and my account is generally a sleepy account.
The above experiment seems to be a success only in terms of the returns. What is not obvious is the effort and the pain behind it. I found myself scouring the internet and bse website for news and tips. In addition, I found myself checking the stock price several times in a day. There was definite change in my thought process as I found myself more anxious, stressed and reacting more and more to daily news.
I realized that my short term approach started infecting my long term though process too. I started looking at my long term holding frequently and started getting more anxious about them. One fine morning, I just plugged the plug and stopped all the trading. Life is good now and back to normal 🙂
A typical experience?
So does it mean long term investors should not trade? No, it only means that I should not trade because I do not have the temperament to do it.
The point of the post it this – One should invest based on one’s own temperament. Some people like fast paced action and the adrenaline rush, so trading may the right approach for them. I prefer a slower and more sedate approach where I will analyze a company for a long time and then slowly build my position. Now if that nets me lower returns, then so be it! Atleast I will sleep well at night and not check stock prices continuously during the day.
Quick analysis – Patels airtemp
About
Patels airtemp is in the business of condensers, heat exchangers and air conditioners. The company is in the same industry and business space as Blue star limited which is a better known company. You can find more about the company here
Financials
The company has been business since 1973, but has started doing well for the last 5 years. The ROE of the company has increased from 7% to around 30% in 2009. The company is almost debt free and may have some excess cash by the end of 2010.
The company had a revenue of 72 Crs and 8.7 cr net profit in 2010.
Positives
The company has grown its topline by more than 30% and bottom line 40%+ in the last 6 years. However at the same time the growth has come from extremely small base. The company has paid off its debt and is now debt free.
The company has a fairly diverse clientele and supplies its products to a wide variety of industries such as cement, chemicals, petrochemicals, textiles and engineering. In addition the company has the benefit of an ever expanding and growing market for its products.
Risks
The company is in a very competitive business with competitive advantages related to scale of operations. A substantial portion of the business comes from projects which involves competitive bidding. The company has started growing in the last few years and it remains to be seen if the company will scale up and enter the big leagues.
The current margins are in the range of 10%+. Blue star which is in a similar business has margins in the range of 5-7%. The ROE for both the companies is in the same range as Blue star is a more efficient user of capital compared to Patels airtemp. The efficiency is mainly to the size of the company. The difference in margins could be due to the pricing/ quoting approach of the companies.
If blue star is more aggressive in bidding, then we are likely to see Patels airtemp follow the same path if it intends to grow beyond the current size. If this happens, we are likely to see a reduction in net margins, though the bottom line could still grow with the topline.

Conclusion
One can look at the financials of the company and assume that patels airtemp would continue to grow at the same rate. If one can make an assumption or have a strong reason to believe that the performance of the last 4-5 years will be repeated then the company is a bargain.
At the same time, one should also consider the fact that the company has been in the biz since 1973 and managed to grow to just 16 crs in the first 30 yrs. The rapid growth and improvement in the performance has come in the last 6 years.
I personally have not been able to make up mind on which scenario will play out and plan to follow the company and dig deeper. It is easy to assume that the company will repeat the performance of the last 6 years, declare the company to be undervalued and buy into it. I however would prefer to investigate deeper and watch the company for a while before buying into it.
